Images List Premium Download Classic

Prophylactic

Prophylactic-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Method for modulating car-induced immune cells activity
Cellectis
October 12, 2017 - N°20170292118

The present invention relates to a method to modulate the level of activation of an engineered immune cell (such as a chimeric antigen receptor t-cell) for immunotherapy. The present invention also relates to cells obtained by the present method, preferably comprising said modulable/tunable chimeric antigen receptors for use in therapeutic or prophylactic treatment.
Compositions and methods for the modulation of ras proteins
New York University
October 12, 2017 - N°20170291958

Described herein is a method of modulating sumoylation of a ras protein by small ubiquitin-like modifier (sumo) proteins. Provided herein is a method for regulating the activity of a ras protein. Also provided is a treatment of proliferative diseases, such as cancer, by introducing specific mutations to a mutant ras protein that is associated with the proliferative disease. Described herein ...
Composition for preventing or treating hyperlipidemia
Hawon Pharm. Corporation
October 12, 2017 - N°20170290874

A pharmaceutical composition for preventing or treating hyperlipidemia includes a salvia miltiorrhiza extract, a crataegus pinnatifida extract, a polygonum multiflorum extract, and a ligusticum chuanxiong extract, thereby reducing the amounts of serum cholesterol and ldl-cholesterol and increasing the amount of hdl-cholesterol; significantly reduces the amount of serum triglyceride compared with existing statin-based drugs, thereby exhibiting prophylactic and therapeutic effects of ...
Prophylactic Patent Pack
Download 224+ patent application PDFs
Prophylactic Patent Applications
Download 224+ Prophylactic-related PDFs
For professional research & prior art discovery
inventor
  • 224+ full patent PDF documents of Prophylactic-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Oral adsorbent and method for producing oral adsorbent
Power Japan Plus Inc.
October 12, 2017 - N°20170290856

Activated carbon (for example medicinal carbon), which has long been used for adsorbing and removing harmful substances from the digestive system, has the drawback of causing constipation, and the production of a spherical adsorbent carbon that is believed to overcome this drawback from a petroleum-based hydrocarbon requires a complicated production process. These issues can be addressed by an oral adsorbent, ...
Immune system modulation for prophylaxis and treatment of diseases and disorders
Marpe Holdings, Llc
October 05, 2017 - N°20170283460

The invention is directed to biological response modifiers (brm) which may contain one or more compounds, and to methods for enhancement of an immune system with brms of the invention including augmenting a specific immune response either prophylactically or for treatment, as an adjuvant or vaccine when coupled with a pathogenic antigen, and for boosting an immune system generally. The ...
Anti-tem1 antibodies and uses thereof
The Trustees Of The University Of Pennsylvania
October 05, 2017 - N°20170281793

The invention relates to anti-tem 1 antibodies or antigen-binding fragments thereof, yeast libraries comprising the same, and prophylactic, diagnostic, and therapeutic methods using the same.
Prophylactic Patent Pack
Download 224+ patent application PDFs
Prophylactic Patent Applications
Download 224+ Prophylactic-related PDFs
For professional research & prior art discovery
inventor
  • 224+ full patent PDF documents of Prophylactic-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Therapeutic or prophylactic agent for itching skin diseases
Toray Industries, Inc.
October 05, 2017 - N°20170281727

An antimicrobial peptide ll-37 has an action to promote expression of a nerve repulsion factor sema3a. Ll-37 is a peptide composed of the c-terminal 37 residues of human cathelicidin hcap18. Use of this antimicrobial peptide enables normalization of expression of axon guidance molecules such as nerve repulsion factor in lesions of pruritic dermatoses including atopic dermatitis and xeroderma, and thus ...
Liposome-based mucus-penetrating particles for mucosal delivery
Kennedy Krieger Institute, Inc.
October 05, 2017 - N°20170281541

Liposome-based mucus-penetrating particles (mpp) capable of loading hydrophilic agents including therapeutic, prophylactic and diagnostic agents such as the diacest mri contrast agent barbituric acid (ba) were evaluated to determine how to optimize delivery. Polyethylene glycol (peg)-coated liposomes containing ≧7 mol % peg diffused only approximately 10-fold slower in human cervicovaginal mucus (cvm) compared to their theoretical speeds in water. 7 mol %...
Method for the prophylactic treatment of a food product silo
Solvay Sa
October 05, 2017 - N°20170280736

A method for the prophylactic treatment of the development of parasites in a food product storage silo, the food product storage generating the deposit of food product scraps and/or dust on the walls of the silo, said prophylactic treatment method comprising the application, to at least one part of the walls, of a layer comprising at least 10 g of ...
Anti-inflammatory peptides and composition comprising the same
Gemvax & Kael Co., Ltd.
September 28, 2017 - N°20170275603

The present invention relates to a peptide with anti-inflammatory activity, wherein the peptide comprises any one amino acid sequence of seq id no:1 to seq id no: 161, the peptide has above 80% homology of amino acid sequence with above-mentioned sequences, or the peptide is the fragment of the above-mentioned peptides. The present invention also relates to an inflammatory composition comprising the ...
Antibodies and molecules derived therefrom that bind to steap-1 proteins
Agensys, Inc.
September 28, 2017 - N°20170275377

Antibodies and molecules derived therefrom that bind to novel steap-1 protein, and variants thereof, are described wherein steap-1 exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers listed in table i. Consequently, steap-1 provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer. The steap-1 gene or fragment thereof, or its encoded protein, ...
Apparatus and method for the prophylaxis of hearing impairment or vertigo
Agensys, Inc.
September 28, 2017 - N°20170274219

The invention relates to an irradiation apparatus for the prophylaxis of hearing impairment and/or vertigo, to a system of functionally connected apparatus components which interact with each other, and a method that uses the irradiation apparatus for the prophylactic irradiation of the inner ear with photons in order to prevent hearing impairment and/or vertigo in a wearer of ...
Cancer stem cell-targeted cancer therapy
Agensys, Inc.
September 28, 2017 - N°20170274058

The present invention provides methods for stabilizing, reducing or eliminating cancer cells. In particular, the present invention provides prophylactically and/or therapeutically effective regimens for the prevention, treatment and/or management of cancer, the regimens comprising administering one or more cancer therapies to a subject to reduce a cancer cell population. The therapy(ies) in the prophylactically and/or therapeutically ...
Prophylactic Patent Pack
Download 224+ patent application PDFs
Prophylactic Patent Applications
Download 224+ Prophylactic-related PDFs
For professional research & prior art discovery
inventor
  • 224+ full patent PDF documents of Prophylactic-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Composition for preventing the occurrence of cardiovascular event in multiple risk patient
Mochida Pharmaceutical Co., Ltd.
September 28, 2017 - N°20170273928

Disclosed is a composition which is useful for preventing the occurrence of a cardiovascular event, particularly a composition which is expected to show a prophylactic effect on a cardiovascular event occurring in a hypercholesterolemia patient despite providing the patient with a treatment with hmg-coa ri or a cardiovascular event occurring in a multiple risk patient.
5'-triphosphate oligoribonucleotides
Oregon Health & Science University
September 21, 2017 - N°20170268007

Disclosed herein are synthetic oligoribonucleotides that form hairpin loop structures. The oligoribonucleotides can be used in the treatment of viral infection including prophylactic treatments. The oligoribonucleotides can also be used as adjuvants.
Single domain antibodies directed against intracellular antigens
Singh Molecular Medicine, Llc
September 21, 2017 - N°20170267784

This invention provides compositions and methods to treat a condition or disease without the use of exogenous targeting sequences or chemical compositions. The present invention relates to single-domain antibodies (sdabs), proteins and polypeptides comprising the sdabs that are directed against intracellular components that cause a condition or disease. The invention also includes nucleic acids encoding the sdabs, proteins and polypeptides, ...
Napi2b-targeted antibody-drug conjugates and methods of use thereof
Mersana Therapeutics, Inc.
September 21, 2017 - N°20170266311

This disclosure provides napi2b-targeted antibody-drug conjugates (e. G., napi2b-targeted antibody-polymer-drug conjugates) that specifically bind to the extracellular region of slc34a2, and to methods of using such conjugates in a variety of therapeutic, diagnostic, and prophylactic indications.
Prevention or treatment agent for hepatic fibrosis
Prism Pharma Co., Ltd.
September 21, 2017 - N°20170266212

Cbp/β-catenin inhibitor shows a superior defibrosing effect for cre/loxp/hcv-mxcre transgenic mouse which is an 5 animal experiment model of hepatic fibrosis, and useful as a prophylactic or therapeutic drug for hepatic fibrosis.
Lipid vesicle compositions and methods of use
Massachusetts Institute Of Technology
September 21, 2017 - N°20170266114

The invention provides delivery systems comprised of stabilized multilamellar vesicles, as well as compositions, methods of synthesis, and methods of use thereof. The stabilized multilamellar vesicles may comprise prophylactic, therapeutic and/or diagnostic agents.
Methods and compositions for treating migraine and conditions associated with pain
Achelios Therapeutics, Inc.
September 21, 2017 - N°20170266106

The present invention relates to pharmaceutical compositions of an non-steroidal anti-inflammatory drug (nsaids) such as, aspirin, diclofenac, ibuprofen, ketoprofen, or naproxen, or any pharmaceutically acceptable salts, solvates, or prodrugs thereof, and the medical use of these compositions. The compositions, which can be formulated for topical administration, can provide extended release of the nsaids. The compositions of the invention are useful, ...
Protein-based therapy and diagnosis of tau-mediated pathology in alzheimer's disease
Axon Neuroscience Se
September 14, 2017 - N°20170260263

The invention provides unique therapeutic and diagnostic antibodies, as well as their fragments, portions, derivatives, and variants thereof, that bind regions of the tau protein that contribute to the initiation and propagation of pathological tau-tau interactions, as well as methods of making them. The invention also relates to methods of using those antibodies for diagnostics, prevention, and treatment of alzheimer's ...
Loading